Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 06 Jul 2026 for TAKEDA PHARMACEUTICAL CO LTD.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Kimberly A. Reed: trading record in brief
Kimberly A. Reed (board member) discloses dealings in 2 companies, chiefly Momentus Inc. and Takeda Pharmaceutical Co Ltd. Between 30 May 2022 and 1 July 2026, the trades on record add up to 8 filings.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 6 July 2026 came the latest disclosure, a share grant in Takeda Pharmaceutical Co Ltd. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Kimberly A. Reed
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
3,800 shares0Ordinary SharesSEC:0001395064-26-000274:0
16,294 shares0Class A Common StockSEC:0001781162-25-000025:0
222 shares0Class A Common StockSEC:0001781162-24-000014:0
11,111 shares0Class A Common StockSEC:0001781162-23-000048:0
86,206 shares0Class A Common StockSEC:0001781162-23-000031:0
11,111 shares0Class A Common StockSEC:0001781162-22-000085:0
17,857 shares0Class A Common StockSEC:0001781162-22-000068:0
7 of 7 declarations
